Histopathologcial and clonal study of combined lobular and ductal carcinoma of the breast

Pathology International

Volumn 63, Issue 6, 2013, Pages 297-304

  Tazaki, Eri ^a   Shishido Hara, Yukiko ^a   Mizutani, Natsuko ^a   Nomura, Sachiyo ^b   Isaka, Hirotsugu ^a   Ito, Hiroki ^a   Imi, Kentaro ^a   Imoto, Shigeru ^a   Kamma, Hiroshi ^a  

^a KYORIN UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Breast cancer; Ductal carcinoma; Human androgen receptor (HUMARA) gene; Lobular carcinoma; Methylation specific PCR

Indexed keywords

ANDROGEN RECEPTOR; BETA CATENIN; UVOMORULIN; AR PROTEIN, HUMAN; CADHERIN; CTNNB1 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; BREAST CARCINOMA; CANCER GENETICS; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CLONAL VARIATION; CONTROLLED STUDY; CYTOLOGY; FEMALE; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METHYLATION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; X CHROMOSOME INACTIVATION; BREAST; BREAST TUMOR; DNA METHYLATION; GENETICS; INTRADUCTAL CARCINOMA; JAPAN; LUNG CARCINOMA; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR; TUMOR INVASION;

ADULT; AGED; BETA CATENIN; BREAST; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DNA METHYLATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; RECEPTORS, ANDROGEN; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84879439105     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/pin.12065     Document Type: Article

References (32)

1. Abdel-Fdatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: Further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 2008; 32: 513-523.
2. Wellings SR, Jensen HM, Marcum RG. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975; 55: 231-273.
3. Jensen HM, Rice JR, Wellings SR. Preneoplastic lesions in the human breast. Science 1976; 191: 295-297.
4. Andersen JA. Lobular carcinoma in situ. A histologic study of 52 cases. Acta Pathol Microbiolo Scand 1974; 82: 735-741.
5. Andersen JA. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer 1977; 39: 2597-2602.
6. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737-769.
7. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: An update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 1998; 122: 1053-1055.
8. Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS. Breast cancer precursors revisited: Molecular features and progression pathways. Histopathology 2010; 57: 171-192.
9. du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Blamey RW. Invasive lobular carcinomas of the breast-the prognosis of histopathological subtypes. Br J Cancer 1989; 60: 605-609.
10. Martinez V, Azzopardi JG. Invasive lobular carcinoma of the breast: Incidence and variants. Histopathology 1979; 3: 467-488.
11. Sastre-Garau X, Jouve M, Asselain B etal. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer 1996; 77: 113-120.
12. Toikkanen S, Pylkkänen L, Joensuu H. Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma. Br J Cancer 1997; 76: 1234-1240.
13. Winchester DJ, Chang HR, Graves TA, Menck HR, Bland KI, Winchester DP. A comparative analysis of lobular and ductal carcinoma of the breast: Presentation, treatment, and outcomes. J Am Coll Surg 1998; 186: 416-422.
14. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001; 115: 85-98.
15. Wagner PL, Kitabayashi N, Chen YT, Shin SJ. Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: A molecular study of 10 cases. Am J Clin Pathol 2009; 132: 871-876.
16. Allen RC, Zoghbi HY, Moseley AB, Rosenblatt HM, Belmont JW. Methylation of HpaII and HhaI sites near the polymorphic CAG repeat in the human androgen-receptor gene correlates with X chromosome inactivation. Am J Hum Genet 1992; 51: 1229-1239.
17. Lyon MF. Gene action in the X-chromosome of the mouse. Nature 1961; 190: 372-373.
18. Lyon MF. Sex chromatin and gene action in the mammalian X chromosome. Am J Hum Genet 1962; 14: 135-148.
19. Tavassoli FA, Devilee P. World Health Organization Classification of Tumours. Pathology & Genetics Tumours of the Breast and Female Genital Organs. Lyon: IARC Press, 2003.
20. Wolff AC, Hammond ME, Schwartz JN etal. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007; 25: 118-145.
21. Going JJ, Abd El-Monem HM, Craft JA. Clonal origins of human breast cancer. J Pathol 2001; 194: 406-412.
22. Kubota T, Nonoyama S, Tonoki H etal. A new assay for the analysis of X-chromosome inactivation based on methylation-specific PCR. Hum Genet 1999; 104: 49-55.
23. Frommer M, McDonald LE, Millar DS etal. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNAstrands. Proc Natl Acad Sci USA 1992; 89: 1827-1831.
24. Clark SJ, Harrison J, Paul CL, Frommer M. High sensitivity mapping of methylated cytosines. Nucleic Acids Res 1994; 22: 2990-2997.
25. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93: 9821-9826.
26. Kim K, Kumagai J, Eishi Y, Ishige I, Ishige Y, Koike M. Clonality analysis for normal and cancerous colon tissues with human androgen receptor gene polymerase chain reaction. J Med Dent Sci 2005; 52: 163-170.
27. Bratthauer GL, Moinfar F, Stamatakos MD etal. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002; 33: 620-627.
28. De Leeuw WJ, Berx G, Vos CB etal. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997; 183: 404-1.
29. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
30. Sung JS, Malak SF, Bajaj P, Alis R, Dershaw DD, Morris EA. Screening breast MR imaging in women with a history of lobular carcinoma in situ. Radiology 2011; 261: 414-420.
31. Choi BB, Kim SH, Park CS, Cha ES, Lee AW. Radiologic findings of lobular carcinoma in situ: Mammography and ultrasonography. J Clin Ultrasound 2011; 39: 59-63.
32. Noguchi S, Aihara T, Koyama H, Motomura K, Inaji H, Imaoka S. Discrimination between multicentric and multifocal carcinomas of the breast through clonal analysis. Cancer 1994; 73: 872-877.